Environmental factors and membrane polyunsaturated fatty acids in schizophrenia

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 69, Issue 6, 2003, Pages 385-391

  Reddy, Ravinder D ^a,b   Yao, Jeffrey K ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Diet; Omega 3 fatty acids; Oxidative stress; Polyunsaturated fatty acids; Schizophrenia; Smoking

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CIGARETTE SMOKE; ESSENTIAL FATTY ACID; FREE RADICAL; MEMBRANE PHOSPHOLIPID; POLYUNSATURATED FATTY ACID;

CIGARETTE SMOKING; DIET; ENVIRONMENTAL FACTOR; ERYTHROCYTE; EXERCISE; FAT INTAKE; HUMAN; LIPID BRAIN LEVEL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 0344441352     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2003.08.009     Document Type: Article

References (70)

1. J. Assies, R. Lieverse, P. Vreken, R.J. Wanders, P.M. Dingemans, D.H. Linszen, Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group, Biol. Psychiatry 49 (2001) 510-522.
2. A.I. Glen, E.M. Glen, D.F. Horrobin, K.S. Vaddadi, M. Spellman, N. Morse-Fisher, K. Ellis, F.S. Skinner, A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases, Schizophr. Res. 12 (1994) 53-61.
3. D.F. Horrobin, M.S. Manku, H. Hillman, A. Iain, M. Glen, Fatty acid levels in the brains of schizophrenics and normal controls, Biol. Psychiatry 30 (1991) 795-805.
4. S.P. Mahadik, S. Mukherjee, D.F. Horrobin, K. Jenkins, E.E. Correnti, R.E. Scheffer, Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects, Psychiatry Res. 63 (1996) 133-142.
5. M. Peet, J.D. Laugharne, J. Mellor, C.N. Ramchand, Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation, Prostaglandins Leukot. Essent. Fatty Acids 55 (1996) 71-75.
6. J.K. Yao, O.P. van Kammen, J.A. Welker, Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition, Schizophr. Res. 13 (1994) 217-226.
7. J.K. Yao, S. Leonard, R.D. Reddy, Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients, Schizophr. Res. 42 (2000) 7-17.
8. K.S. Vaddadi, P. Courtney, C.J. Gilleard, M.S. Manku, D.F. Horrobin, A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia, Psychiatry Res. 27 (1989) 313-323.
9. R. Reddy, M.S. Keshavan, J.K. Yao, Reduced red blood cell membrane essential polyunsaturated fatty acids in first-episode schizophrenia at neuroleptic-naïve baseline, Schizophr. Bull., in press.
10. M. Arvindakshan, S. Sitasawad, V. Debsikdar, M. Ghate, D. Evans, D.F. Horrobin, C. Bennett, P.K. Ranjekar, S.P. Mahadik, Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients, Biol. Psychiatry 53 (2003) 56-64.
11. D.R. Evans, V.V. Parikh, M.M. Khan, C. Coussons, P.F. Buckley, S.P. Mahadik, Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment, Prostaglandins Leukot. Essent. Fatty Acids, this issue, doi:10.1016/j.plefa.2003.08.010.
12. S.P. Mahadik, S. Mukherjee, E. Correnti, H.S. Kelkar, C.G. Wakade, R.M. Costa, R. Scheffer, Distribution of plasma membrane phospholipids and cholesterol in skin fibroblasts from drug-naïve patients at the onset of psychosis, Schizophr. Res. 13 (1994) 239-247.
13. D.F. Horrobin, Schizophrenia as a membrane lipid disorder which is expressed throughout the body, Prostaglandins Leukot. Essent. Fatty Acids 55 (1996) 3-7.
14. J.R. Hibbeln, K.K. Makino, C.E. Martin, F. Dickerson, J. Boronow, W.S. Fenton, Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder, Biol. Psychiatry 53 (2003) 431-441.
15. Anonymous, Smoking habits and plasma lipid peroxide and vitamin E levels in never-treated first-episode patients with schizophrenia, Scottish Schizophrenia Research Group, Br. J. Psychiatry 176 (2000) 290-293.
16. J.R. Hughes, D.K. Hatsukami, J.E. Mitchell, L.A. Dahlgren, Prevalence of smoking among psychiatric outpatients, Am. J. Psychiatry 143 (1986) 993-997.
17. L. Llerena, A. de la Rubia, E.M. Penas-Lledo, FJ. Diaz, J. de Leon, Schizophrenia and tobacco smoking in a Spanish psychiatric hospital, Schizophr. Res. 58 (2002) 323-327.
18. J.B. Lohr, K. Flynn, Smoking and schizophrenia, Schizophr. Res. 8 (1992) 93-102.
19. A. Olincy, D.A. Young, R. Freedman, Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers, Biol. Psychiatry 42 (1997) 1-5.
20. M.J. Lyons, J.L. Bar, W.S. Kremen, R. Toomey, S.A. Eisen, J. Goldberg, S.V. Faraone, M. Tsuang, Nicotine and familial vulnerability to schizophrenia: a discordant twin study, J. Abnorm. Psychol. 111 (2002) 687-693.
21. H.H. Stassen, R. Bridler, S. Hagele, M. Hergersberg, B. Mehmann, A. Schinzel, M. Weisbrod, C. Scharfetter, Schizophrenia and smoking: evidence for a common neurobiological basis?, Am. J. Med. Genet. 96 (2000) 173-177.
22. L. Packer, M. Hiramatsu, T. Yoshikawa (Eds.), Free Radicals in Brain Physiology and Disorders, Academic Press, New York, 1996.
23. J.B. Lohr, Oxygen radicals and neuropsychiatric illness. Some speculations, Arch. Gen. Psychiatry 48 (1991) 1097-1106.
24. D.F. Church, W.A. Pryor, Free-radical chemistry of cigarette smoke and its toxicological implications, Environ. Health Perspect. 64 (1985) 111-126.
25. B.K. Do, H.S. Garewal, N.C. Clements Jr., Y.M. Peng, M.P. Habib, Exhaled ethane and antioxidant vitamin supplements in active smokers, Chest 110 (1996) 159-164.
26. B. Halliwell, Cigarette smoking and health: a radical view, J. R. Soc. Health 113 (1993) 91-96.
27. R. Reddy, J.K. Yao, Membrane protective strategies in schizophrenia: conceptual and treatment issues, in: A.I.M. Glen, M. Peet, D.F. Horrobin (Eds.), Phospholipid Spectrum Disorder in Psychiatry, Marius Press, Lancashire, UK, 1999, pp. 75-88.
28. A.M. Papas, Determinants of antioxidant status in humans, Lipids 31 (1996) S77-82.
29. J.P. Eiserich, A. van der Vliet, G.J. Handelman, B. Halliwell, C.E. Cross, Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction, Am. J. Clin. Nutr. 61 (1995) 1490S-1500S.
30. J.D. Lane, E.C. Opara, J.E. Rose, F. Behm, Quitting smoking raises whole blood glutathione, Physiol. Behav. 60 (1996) 1379-1381.
31. S. Brown, Excess mortality of schizophrenia. A meta-analysis, Br. J. Psychiatry 171 (1997) 502-508.
32. E.R. Miller III, L.J. Appel, L. Jiang, T.H. Risby, Association between cigarette smoking and lipid peroxidation in a controlled feeding study, Circulation 96 (1997) 1097-1101.
33. 2-isoprostanes) in smokers. Smoking as a cause of oxidative damage, N. Engl. J. Med. 332 (1995) 1198-1203.
34. S.A. Hulea, R. Olinescu, S. Nita, D. Crocnan, F.A. Kummerow, Cigarette smoking causes biochemical changes in blood that are suggestive of oxidative stress: a case-control study, J. Environ. Pathol. Toxicol. Oncol. 14 (1995) 173-180.
35. G. Block, M. Dietrich, E.P. Norkus, J.D. Morrow, M. Hudes, B. Caan, L. Packer, Factors associated with oxidative stress in human populations, Am. J. Epidemiol. 156 (2002) 274-285.
36. M.B. Leonard, K. Lawton, I.D. Watson, I. MacFarlane, Free radical activity in young adult cigarette smokers, J. Clin. Pathol. 48 (1995) 385-387.
37. K.M. Brown, P.C. Morrice, J.R. Arthur, G.G. Duthie, Effects of vitamin E supplementation on erythrocyte antioxidant defence mechanisms of smoking and non-smoking men, Clin. Sci. (London) 91 (1996) 107-111.
38. B.K. Do, H.S. Garewal, N.C. Clements Jr., Y.M. Peng, M.P. Habib, Exhaled ethane and antioxidant vitamin supplements in active smokers, Chest 110 (1996) 159-164.
39. K.T. Zondervan, M.C. Ocke, H.A. Smit, J.C. Seidell, Do dietary and supplementary intakes of antioxidants differ with smoking status? (cited in [65]).
40. M.O. Faruque, M.R. Khan, M.M. Rahman, F. Ahmed, Relationship between smoking and antioxidant nutrient status, Br. J. Nutr. 73 (1995) 625-632.
41. B. Krijgsman, J.A. Papadakis, E.S. Ganotakis, O.P. Mikhailidis, G. Hamilton, The effect of peripheral vascular disease on the serum levels of natural anti-oxidants: bilirubin and albumin, Int. Angiol. 21 (2002) 44-52.
42. H.A. Schwertner, Association of smoking and low serum bilirubin antioxidant concentrations, Atherosclerosis 136 (1998) 383-387.
43. M. Dietrich, G. Block, E.P. Norkus, M. Hudes, M.G. Traber, C.E. Cross, L. Packer, Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo after adjustment for dietary antioxidant intakes, Am. J. Clin. Nutr. 77 (2003) 160-166.
44. C. Berry, C. Montgomery, N. Sattar, J. Norrie, L.T. Weaver, Fatty acid status of women of reproductive age, Eur. J. Clin. Nutr. 55 (2001) 518-524.
45. J.C. Seidell, M. Cigolini, J.P. Deslypere, J. Charzewska, B.M. Ellsinger, Polyunsaturated fatty acids in adipose tissue in European men aged 38 years in relation to serum lipids, smoking habits, and fat distribution, Am. J. Epidemiol. 134 (1991) 583-589.
46. C. Agostoni, F. Marangoni, M. Giovannini, E. Riva, C. Galli, Long-chain polyunsaturated fatty acids, infant formula, and breastfeeding, Lancet 352 (1998) 1703-1704.
47. P. Rise, F. Marangoni, C. Galli, Regulation of PUFA metabolism: pharmacological and toxicological aspects, Prostaglandins Leukot. Essent. Fatty Acids 67 (2002) 85-89.
48. R.L. Thompson, B.M. Margetts, Comparison of a food frequency questionnaire with a 10-day weighed record in cigarette smokers, Int. J. Epidemiol. 22 (1993) 824-833.
49. J.A. Simon, J. Fong, J.T. Bernert Jr., W.S. Browner, Relation of smoking and alcohol consumption to serum fatty acids, Am. J. Epidemiol. 144 (1996) 325-334.
50. R. Pawlosky, J. Hibbeln, B. Wegher, N. Sebring, N. Salem Jr., The effects of cigarette smoking on the metabolism of essential fatty acids, Lipids 34 (1999) S287.
51. Y.K. Yang, J.P. McEvoy, W.H. Wilson, E.D. Levin, J.E. Rose, Reliabilities and intercorrelations of reported and objective measures of smoking in patients with schizophrenia, Schizophr. Res. 60 (2003) 9-12.
52. D.F. Horrobin, Omega-3 fatty acid for schizophrenia, Am. J. Psychiatry 160 (2003) 188-189 (author reply 189).
53. J.K. Yao, R.D. Reddy, Membrane pathology in schizophrenia: implication for arachidonic acid signaling, Curr. Med. Chem. Central Nervous Syst. Agent 3 (2003) 57-65.
54. P. Morell, A.D. Toews, Biochemistry of lipids, in; H.W. Moser (Ed.), Handbook of Clinical Neurology, Vol. 22: Neurodystrophies and Neurolipidoses, Elsevier, Amsterdam, 1996, pp. 33-49.
55. M. Haag, Essential fatty acids and the brain, Can. J. Psychiatry 48 (2003) 195-203.
56. L. Lauritzen, H.S. Hansen, M.H. Jorgensen, K.F. Michaelsen, The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina, Prog. Lipid Res. 40 (2001) 1-94.
57. S.P. Mahadik, M. Mulchandani, M.V. Hegde, P.K. Ranjekar, Cultural and socioeconomic differences in dietary intake of essential fatty acids and antioxidants - effects on the outcome, in: A.I.M. Glen, M. Peet, D.F. Horrobin (Eds.), Phospholipid Spectrum Disorder in Psychiatry, Marius Press, Lancashire, UK, 1999, pp. 167-179.
58. H.W. Hoek, A.S. Brown, E. Susser, The Dutch famine and schizophrenia spectrum disorders, Soc. Psychiatry Psychiatr. Epidemiol. 33 (1998) 373-379.
59. H.E. Hulshoff Pol, H.W. Hoek, E. Susser, A.S. Brown, A. Dingemans, H.G. Schnack, N.E. van Haren, L.M. Pereira Ramos, C.C. Gispen-de Wied, R.S. Kahn, Prenatal exposure to famine and brain morphology in schizophrenia, Am. J. Psychiatry 157 (2000) 1170-1172.
60. M. Amore, C. Balista, R.G. McCreadie, C. Cimmino, F. Pisani, G. Bevilacqua, G. Ferrari, Can breast-feeding protect against schizophrenia? Case-control Study, Biol. Neonate 83 (2003) 97-101.
61. R.M. Dougherty, C. Galli, A. Ferro-Luzzi, J.M. Iacono, Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: a study of normal subjects from Italy, Finland, and the USA, Am. J. Clin. Nutr. 451 (1987) 443-455.
62. J.L. Stanford, I. King, A.R. Kristal, Long-term storage of red blood cells and correlations between red cell and dietary fatty acids: results from a pilot study, Nutr. Cancer 16 (1991) 183-188.
63. M. Strassnig, J.S. Brar, R. Ganguli, Nutritional assessment of patients with schizophrenia. Schizophr. Bull., in press.
64. A.P. Simopoulos, Human requirement for N-3 polyunsaturated fatty acids, Poult. Sci. 79 (2000) 961-970.
65. L. Zhou, A. Nilsson, Sources of eicosanoid precursor fatty acid pools in tissues, J. Lipid Res. 42 (2001) 1521-1542.
66. R.T. Holman, Essential fatty acid deficiency in humans, in: C. Galli, G. Jacini, A. Pecile (Eds.), Dietary Lipids and Postnatal Development, Raven Press, New York, 1973, pp. 127-143.
67. D.F. Horrobin, M.S. Manku, N. Morse-Fisher, K.S. Vaddadi, P. Courtney, A.I. Glen, E. Glen, M. Spellman, C. Bates, Essential fatty acids in plasma phospholipids in schizophrenics, Biol. Psychiatry 25 (1989) 562-568.
68. H. Kaiya, D.F. Horrobin, M.S. Manku, N.M. Fisher, Essential and other fatty acids in plasma in schizophrenics and normal individuals from Japan, Biol. Psychiatry 30 (1991) 357-362.
69. D.G. Kirch, Nicotine and major mental disorders, in: M. Piassecki, P.A. Newhouse (Eds.), Nicotine in Psychiatry: Psychopathology and Emerging Therapeutics, American Psychiatric Press, Washington, DC, 2000, pp. 111-130.
70. D.V. Jeste, J.A. Gladsjo, L.A. Lindamer, J.P. Lacro, Medical comorbidity in schizophrenia, Schizophr. Bull. 22 (1996) 413-430.